Anthony Saleh

Co-founder and CEO

‍MiRecule Inc

Co-founder and CEO

‍MiRecule Inc

#FlowCytometry #MolecularBiology #qPCR

#NorthAmerica

Anthony Saleh is the founder and CEO of MiRecule, a biotech startup that is focused on developing small-molecule therapeutics to treat cancer and other diseases. MiRecule is based in Boston, Massachus

Baochun Zhang

Assistant Professor of Medicine

‍Dana-Farber Cancer Institute, Harvard Medical School

Assistant Professor of Medicine

‍Dana-Farber Cancer Institute, Harvard Medical School

#qpcr #molecularbiology

#NorthAmerica

After studying Medicine in China, Dr. Zhang pursued Ph.D training at the Medical College of Ohio, where he studied T cell tolerance and B cell lymphomagenesis. He then had his postdoctoral training wi

Erwan Scolan

Oncology Director

‍CytomX Therapeutics

Oncology Director

‍CytomX Therapeutics

#molecularbiology #qpcr

#NorthAmerica

Cell biologist with more than 10 years of post-Ph.D.

Joshua Heiber

Director

‍Alkermes

Director

‍Alkermes

#flowcytometry #qpcr

#NorthAmerica

Joshua has experience in advanced multi-parameter (17 color) flow cytometry (BD LSR-II, Fortessa, FACS Celesta and Attune Cytometers), Flowjo based TSNE analysis of high parameter flow data, Confocal